Recent advancements in microfabrication of microfluidic chips are pushing the boundaries of nanoparticle design, offering new possibilities for drug delivery and biotechnology applications. A team of researchers has developed a novel method for creating nanoscale liposomes with enhanced structural complexity, addressing longstanding limitations in the field.
Existing soft-matter nanoparticles, such as liposomes, have been constrained by their simplistic structures, typically consisting of a single membrane-bound aqueous compartment. This lack of architectural complexity has limited their functional scope, particularly in areas requiring precise control over multiple payload release or compartmentalized reactions.
“Given that form and function are intertwined, this lack of architectural complexity restricts the development of more sophisticated properties. To address this, we have devised an engineering strategy combining microfluidics and conjugation chemistry to synthesize nanosized liposomes with two discrete compartments, one within another, which we term concentrisomes “, the authors explained.
“a, A graphic illustrating the steps involved in the click-chemistry-assisted microfluidic synthesis of concentrisomes. A liposome suspension with alkyne moieties is fed into a MHF chip as a sheathing buffer stream, which is co-flowed alongside a secondary lipid composition that contains azide-functionalized lipids dissolved in ethanol. Micellar/bicellar aggregates tether to the external leaflet of pre-formed vesicles and eventually close to generate a second bilayer. The DBCO moiety, azide and triazole product are represented by a yellow triangle, green star and pink pentagon, respectively. The corresponding chemical structures are shown to the right of each graphic. A representative cryo-TEM micrograph of the concentrisome (double-bilayer liposome) is given on the right. Scale bar, 200 nm. b, A graphical illustration of possible concentrisome functionality: multi-cargo encapsulation in different compartments, triggered sequential multi-stage release of two different payloads, and in situ biochemical synthesis within the attolitre volume of the particle itself, followed by release.” Reproduced from Pilkington, C.P., Gispert, I., Chui, S.Y. et al. Engineering a nanoscale liposome-in-liposome for in situ biochemical synthesis and multi-stage release. Nat. Chem. (2024). under a CC BY 4.0 Attribution 4.0 International license
The “concentrisomes” are nanoscale liposomes with two discrete compartments, one nested within another. Their method combines microfluidic hydrodynamic focusing (MHF) with conjugation chemistry, allowing unprecedented control over particle architecture and composition.The concentrisomes exhibited the capability for multi-stage and site-specific release of encapsulated agents. This was achieved by designing bilayers to respond to predetermined external stimuli, thus allowing for the controlled release of substances at specific times and locations. Such a feature is particularly beneficial for applications requiring the simultaneous delivery of multiple drugs with precise timing, such as in combination therapy.
The synthesis process involves two key steps utilizing microfluidic devices:
The researchers incorporated click chemistry (specifically, strain-promoted azide/alkyne cycloaddition) to facilitate the formation of the outer bilayer and control inter-bilayer spacing. This approach allows precise control over:
The microfluidic synthesis method yielded concentrisomes with several notable properties:
The development of concentrisomes marks a significant step forward in the design of nanoparticle systems for complex drug delivery and synthetic biology applications. Their ability to mimic biological compartmentalization, combined with the precision in functional design, opens up new avenues in targeted therapy and on-demand biochemical processes.
As research in this area progresses, we can expect to see further refinements in microfluidic microfabrication techniques and exploration of diverse applications for these sophisticated nanoparticles. The integration of this technology with other lab-on-chip modules for downstream processes like purification and sterilization presents exciting opportunities for future development in the field of nanomedicine and biotechnology.
Figures are reproduced from Pilkington, C.P., Gispert, I., Chui, S.Y. et al. Engineering a nanoscale liposome-in-liposome for in situ biochemical synthesis and multi-stage release. Nat. Chem. (2024). https://doi.org/10.1038/s41557-024-01584-z under a CC BY 4.0 Attribution 4.0 International license.
Read the original article: Engineering a nanoscale liposome-in-liposome for in situ biochemical synthesis and multi-stage release
For more insights into the world of microfluidics and its burgeoning applications in biomedical research, stay tuned to our blog and explore the limitless possibilities that this technology unfolds. If you need high quality microfluidics chip for your experiments, do not hesitate to contact us.
Despite the significant advancements brought by immune checkpoint inhibitors (ICIs) in melanoma treatment, patient responses…
Traditional developmental toxicity (DevTox) studies largely rely on mammalian models to assess chemical impacts on…
Circulating tumor cells (CTCs) hold the potential for cancer diagnosis and monitoring, offering a non-invasive…
Leukocyte differentiation and counting are critical for clinical diagnostics but are hindered by the low…
Screening for microbial proteolytic activity is essential in various biotechnological applications, including bioenergy, food processing,…
Understanding how cellular components, especially chromatin and nuclear condensates, respond to mechanical forces during confined…